show episodes
 
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine. Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixe ...
  continue reading
 
Loading …
show series
 
Some people may lose too much muscle with weight loss medication. In preventing or rebuilding lost muscle, which is more important - dietary protein or physical activity? Learn more: https://drsue.ca/2024/06/preventing-or-rebuilding-muscle-loss-from-weight-loss-medication-is-dietary-protein-or-exercise-more-important/ Any medical discussion on this…
  continue reading
 
Elevated weight can be a cause or contributor to hypertension. Why is it so important to watch your blood pressure if you are on weight management medication? Learn more: https://drsue.ca/2024/06/watching-blood-pressure-on-weight-loss-medication-why-is-this-important/ Any medical discussion on this podcast is intended to be of a general nature only…
  continue reading
 
Obesity: are environmental chemicals at the center of the storm? Find out where these chemicals may reside.... even in our nonstick cookware. Eeew. Learn more: https://drsue.ca/2024/05/obesity-are-environmental-chemicals-at-the-center-of-the-storm/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
We know that GLP1 medications reduce protein in the urine in people with type 2 diabetes and kidney disease, but no study had ever been done to see whether GLP1 treatment could protect kidney function – until now. Learn more: https://drsue.ca/2024/05/semaglutide-first-glp1-medication-proven-to-provide-kidney-protection/ Any medical discussion on th…
  continue reading
 
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped? Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/…
  continue reading
 
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know? Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is n…
  continue reading
 
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
TRANSCRIPT Hi, Sophie here as usual. This is just a very short piece of audio to let you know that the Foodies podcast will be taking a bit of a holiday until the later half of this year. As keen listeners will know, I’m undertaking a PhD at the moment as well as working a part time job. The PhD is coming to the pointy end which means my time and b…
  continue reading
 
As many as 1 BILLION adults worldwide are estimated to have obstructive sleep apnea (OSA), and 70% of people with OSA have obesity. How much does sleep apnea improve with weight loss, and does it matter how the weight is lost (with lifestyle, weight management medication, or bariatric surgery)? Learn more: https://drsue.ca/2024/04/how-much-does-sle…
  continue reading
 
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us? Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/ Any medical discussion on this podca…
  continue reading
 
Older data have shown that obesity medications are prescribed far less frequently than medications for other chronic medical conditions. Much has changed in recent years in the weight management world. How has this impacted prescribing of weight management medication? Learn more: https://drsue.ca/2024/04/how-many-people-with-obesity-actually-receiv…
  continue reading
 
Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know? Learn more: https://drsue.ca/2024/04/mounjaro-ozemp…
  continue reading
 
In this episode Kim Anastasiou, a Research Fellow at the Stretton Health Equity Institute of the University of Adelaide, unpacks the impact that ultra processed foods are having not just on our health but also our environment and what this means for the work we do and the world we live in. Kim is an advocate for the transformative changes needed to…
  continue reading
 
Oprah Winfrey recently hosted a special called 'Shame, Blame, and the Weight Loss Revolution'. What will the Oprah Effect be on obesity medicine? Learn more: https://drsue.ca/2024/03/what-will-the-oprah-effect-be-on-obesity-medicine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian au…
  continue reading
 
Resmetirom is the first treatment ever approved for fatty liver disease. Could GLP1 based obesity/diabetes medications have similar benefits? Learn more: https://drsue.ca/2024/03/first-medication-ever-approved-to-treat-fatty-liver-disease-how-will-glp1-based-obesity-diabetes-medications-stack-up/ Any medical discussion on this podcast is intended t…
  continue reading
 
With the emergence of medications that are very powerful for weight loss, some people may lose too much weight. This can include excessive loss of muscle mass, a condition called sarcopenia. How should we look for and diagnose sarcopenia? Learn more: https://drsue.ca/2024/03/how-can-we-diagnose-sarcopenia-excessive-loss-of-muscle-in-people-successf…
  continue reading
 
The DiRECT 5 year trial of diabetes remission with lifestyle was just published. Does this study suggest that we should 'DiRECT' our patients towards lifestyle treatment alone? Learn more: https://drsue.ca/2024/03/diabetes-remission-should-we-direct-patients-towards-lifestyle-change-alone/ Any medical discussion on this podcast is intended to be of…
  continue reading
 
Guidelines currently recommend lifestyle change as a strategy to achieve diabetes remission. But is diabetes remission with lifestyle change alone a realistic long term goal? Learn more: https://drsue.ca/2024/02/is-diabetes-remission-with-lifestyle-change-a-realistic-long-term-goal/ Any medical discussion on this podcast is intended to be of a gene…
  continue reading
 
Dr. Fiona Willer is an Advanced Accredited Practising Dietitian and Fellow of the Higher Education Academy renowned for her advocacy of weight-neutral practices in healthcare. Throughout the podcast episode, Fiona shares insights on why a weight neutral approach is necessary to progress population wellbeing, and how community health and food practi…
  continue reading
 
Will glucagon with GLP-1 be a new combination weight management treatment? How could these 2 hormones work together to facilitate weight loss? Learn more: https://drsue.ca/2024/02/will-glucagon-with-glp1-be-a-new-combination-weight-management-treatment/ Any medical discussion on this podcast is intended to be of a general nature only, and is intend…
  continue reading
 
There are many important strategies to protect the kidneys of people with type 2 diabetes. Could a longer time at a target weight loss be one of them? Learn more: https://drsue.ca/2024/02/could-spending-more-time-at-a-target-weight-protect-against-kidney-failure-in-people-with-type-2-diabetes/ Any medical discussion on this podcast is intended to b…
  continue reading
 
Rare post marketing case reports of suicidality have emerged amongst people taking GLP1 receptor agonists for diabetes or obesity. What new data do we have on this, and where are global regulatory agencies at in their investigations? Learn more: https://drsue.ca/2024/01/update-are-glp1-receptor-agonist-medications-for-weight-management-and-diabetes…
  continue reading
 
What are the risks associated with the RSV virus, and should you be vaccinated? Learn more: https://drsue.ca/2024/01/should-you-get-the-rsv-vaccine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor…
  continue reading
 
Why do so many people stop weight management medication - and why does it matter? Learn more: https://drsue.ca/2024/01/why-do-so-many-people-stop-their-weight-management-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specifi…
  continue reading
 
We know that elevated weight is a key risk factor for developing type 2 diabetes. Does carrying elevated weight increase the risk of developing autoimmune type 1 diabetes as well? Learn more: https://drsue.ca/2024/01/does-obesity-increase-the-risk-of-developing-autoimmune-type-1-diabetes/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
Weight management medications are expensive, and often on shortage. What happens if we treat intermittently (on and off)? Learn more: https://drsue.ca/2023/12/should-we-consider-on-off-intermittent-treatment-with-weight-loss-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian…
  continue reading
 
Could Alexa AI help people titrate insulin (for diabetes) or GLP1 receptor agonists (for diabetes or weight management)? Learn more: https://drsue.ca/2023/12/could-ai-help-to-optimize-insulin-or-glp1-receptor-agonist-therapy/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. …
  continue reading
 
Miss any key advancements and challenges in the field of weight management in 2023? Join me for the highlights here! Learn more: https://drsue.ca/2023/12/dr-sues-weight-management-highlights-2023/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed …
  continue reading
 
Just how does obesity increase the risk of so many types of cancer? Learn more: https://drsue.ca/2023/12/how-does-obesity-increase-cancer-risk/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to t…
  continue reading
 
Why are there shortages of weight management medication? Should use of diabetes-labeled treatments be denied to people with obesity without diabetes? What does the shortage mean for socioeconomic disparities in health? Learn more: https://drsue.ca/2023/10/shortages-of-weight-management-medication/ Any medical discussion on this podcast is intended …
  continue reading
 
With new and emerging evidence for the benefits of weight management medication far beyond simply weight loss, should we reframe and fine tune our targets further? Learn more: https://drsue.ca/2023/11/weight-management-what-does-it-mean-to-treat-to-target-with-medication/ Any medical discussion on this podcast is intended to be of a general nature …
  continue reading
 
Many women with polycystic ovary syndrome struggle with elevated weight. What do the new guidelines say about weight management? Learn more: https://drsue.ca/2023/11/polycystic-ovary-syndrome-pcos-what-do-the-new-guidelines-say-about-weight-management/ Any medical discussion on this podcast is intended to be of a general nature only, and is intende…
  continue reading
 
Could we detect diabetes with nothing more than a smart phone and internet access? Voice has emerged as a potential candidate for detecting diabetes, with AI technology being explored as a screening tool. Learn more: https://drsue.ca/2023/11/could-ai-detect-diabetes-by-listening-to-your-voice/ Any medical discussion on this podcast is intended to b…
  continue reading
 
Tirzepatide (Mounjaro) is very effective for improvement in blood sugar control and weight loss. Find out about this exciting new addition to Canada's treatment options for type 2 diabetes. Learn more: https://drsue.ca/2023/10/tirzepatide-now-available-in-canada-how-to-with-vial-and-syringe/ Any medical discussion on this podcast is intended to be …
  continue reading
 
What's new with the Freestyle Libre (2 and 3), the Dexcom (G7), and the Medtronic (Guardian 4) in Canada? Learn more: https://drsue.ca/2023/10/advances-in-blood-sugar-monitoring-technology-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not design…
  continue reading
 
Is fat under the skin (subcutaneous) really healthy? Does cutting back food intake by 500 calories per day really result in 1 pound of weight loss per week? Find out the answers to these questions and more! Learn more: https://drsue.ca/2023/09/30-myths-about-obesity-part-1/ Any medical discussion on this podcast is intended to be of a general natur…
  continue reading
 
Does every pound of muscle that replaces fat really burn an extra 50 calories per day? Is slow, gradual weight loss really better than losing a large amount quickly? Find out the answers to these questions and more! Learn more: https://drsue.ca/2023/10/30-myths-about-obesity-part-2/ Any medical discussion on this podcast is intended to be of a gene…
  continue reading
 
What are cravings exactly? And what tools do we have available to combat them? Learn more: https://drsue.ca/2023/09/what-are-cravings-and-how-can-we-reduce-them/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to …
  continue reading
 
Semaglutide 2.4mg (Wegovy) is the first weight management medication ever to show that it reduces cardiovascular events. Read more about this here! Learn more: https://drsue.ca/2023/11/semaglutide-wegovy-first-weight-management-medication-in-the-world-to-show-reduction-in-cardiovascular-events/ Any medical discussion on this podcast is intended to …
  continue reading
 
Rowena Yamazaki is an Accredited Practicing Dietitian from YouthBlock - a specialist youth health service in Sydney. For the last 17 years Rowena has led the Yhunger program which aims to strengthen young people's food literacy skills and improve their food security status. Rowena talks about involving youth throughout all elements of food and nutr…
  continue reading
 
Dr. Sue Kleve is a public health nutrition researcher and senior lecturer with the Department of Nutrition, Dietetics and Food at Monash University. Sue has over 20 years’ experience working across community and public health nutrition settings in Australia. In this episode Sue provides insights into why more and more Australians are experiencing f…
  continue reading
 
Dr Alexandra Jones is a public health lawyer and researcher at The George Institute for Global Health within the Food Policy team. This episode dives deep into the world of food policy and regulation, as Ali explains Front of Pack Labelling around the world with a particular focus on the Australian Health Star Rating. We talk about how this regulat…
  continue reading
 
Helen Vidgen is an Associate Professor in Nutrition and Dietetics at the Queensland University of Technology. This is Part Two of a two-part episode. This episode is all about Helen’s food literacy work and the global impact that it's had.If you’re unsure what food literacy is, why we should be considering it in our everyday work and how we can do …
  continue reading
 
Helen Vidgen is an Associate Professor in Nutrition and Dietetics at the Queensland University of Technology. This is Part One of a Two-part episode. In this first episode we go through Helen’s incredible career journey in public health and community nutrition and dive deep into various topics including the lack of diversity in our workforce, how t…
  continue reading
 
Professor Sharon Friel is an ARC Laureate Fellow, Professor of Health Equity and Director of the Planetary Health Equity Hothouse and the Menzies Centre for Health Governance at the School of Regulation and Global Governance (RegNet) at the Australian National University. On today’s show Sharon talks about investigating the intersection of climate …
  continue reading
 
Dr. Cathy Wilkinson is the CEO of the Stephanie Alexander Kitchen Garden Foundation. The SAKG Foundation provides inspiration, information, professional development and support for educational institutions to deliver pleasurable food education for Australian children in conjunction with educators, partners and the wider community. As Cathy explains…
  continue reading
 
The roles are reversed in this episode with podcast host Sophie Wright-Pedersen in the hotseat being interviewed by Donna Munari. Sophie talks about her public health nutrition journey so far, why she started this podcast and where it might go in the future. Check out all the podcast links below: - Alice Springs Food Security report - Cook Chill Ch…
  continue reading
 
Danielle Gallegos is a Professor in Nutrition and Dietetics at the Queensland University of Technology. With over 30 years of experience, Danielle continues to contribute significantly to public health nutrition work - particularly in the areas of food security, food literacy and early childhood care. Danielle is the Director of the Woolworths Cent…
  continue reading
 
Professor Amanda Lee, of Public Health Policy in the Faculty of Medicine’s School of Public Health at the University of Queensland and Affiliate Professor at the UQ Poche Centre for Indigenous Health. Amanda is a Senior Adviser with The Australian Prevention Partnership Centre, an Adjunct Professor at Curtin University, Griffith University and the …
  continue reading
 
Khia De Silva is the Nutrition Manager at the Arnhem Land Progress Aboriginal Corporation (ALPA). In this episode Khia talks about working as a nutritionist embedded within a retail environment to support the implementation of the ALPA Health and Nutrition strategy across ALPA’s retail businesses in top end Australia. We talk about balancing nutrit…
  continue reading
 
Loading …

Quick Reference Guide